199730 is the Korean stock ticker for BioInfra, a KOSDAQ-listed Korean public company in Business Services & Distribution.
199730 is the Korean stock ticker for BioInfra, a KOSDAQ-listed Korean public company in Business Services & Distribution. Business activity: Contract research organization services. Product/service: Generic drug bioequivalence testing. Product/service: Improved drug Phase I clinical trials. Product/service: Regulatory clinical trials. Product/service: Immunoassays. Product/service: Pharmaceutical quality testing. Product/service: Specimen analysis services.
This ticker has no publisher-linked research report in the current collection.
199730 is a Korean stock ticker that trades on KOSDAQ as a common share tracked by Korean Tickers with data.go.kr daily public data, DART filings, and USD reference values.
BioInfra is classified by Korean Tickers under Business Services & Distribution, with official issuer and industry context shown on the company profile.
| Item | TTM 26 Q2 LTM / latest balance sheet | 26 Q2 Standalone quarter | 26 Q1 Standalone quarter | 2025 Annual | 2024 Annual | Change vs 2025 |
|---|---|---|---|---|---|---|
| Revenue | $18.57M ₩25.6B | $6.16M ₩8.5B | $3.99M ₩5.5B | $16.77M ₩23.1B | $17.27M ₩23.8B | +10.7% |
| Gross Profit | $4.75M ₩6.6B | $1.89M ₩2.6B | $501K ₩691.4M | $3.86M ₩5.3B | $4.13M ₩5.7B | +23.1% |
| Operating Income | - | $55K ₩75.7M | $-1.75M ₩-2.4B | - | - | |
| Net Income | - | $1K ₩1.5M | $-1.81M ₩-2.5B | - | - | |
| Cash & Equivalents | $2.05M ₩2.8B | $2.05M ₩2.8B | $2.15M ₩3.0B | $1.55M ₩2.1B | $2.92M ₩4.0B | +31.9% |
| Current Assets | $8.80M ₩12.1B | $8.80M ₩12.1B | $9.06M ₩12.5B | $8.78M ₩12.1B | $10.70M ₩14.8B | +0.2% |
| Receivables | $2.34M ₩3.2B | $2.34M ₩3.2B | - | $1.28M ₩1.8B | $1.48M ₩2.0B | +82.5% |
| Total Assets | $24.77M ₩34.2B | $24.77M ₩34.2B | $24.98M ₩34.5B | $25.33M ₩35.0B | $29.80M ₩41.1B | -2.2% |
| Current Liabilities | $15.16M ₩20.9B | $15.16M ₩20.9B | $15.36M ₩21.2B | $12.80M ₩17.7B | $6.68M ₩9.2B | +18.4% |
| Total Liabilities | $15.64M ₩21.6B | $15.64M ₩21.6B | $15.90M ₩21.9B | $13.38M ₩18.5B | $9.82M ₩13.6B | +16.9% |
| Total Equity | $9.13M ₩12.6B | $9.13M ₩12.6B | $9.09M ₩12.5B | $11.95M ₩16.5B | $19.98M ₩27.6B | -23.6% |